![]() Online edition of India's National Newspaper Wednesday, Feb 14, 2007 ePaper |
|
|
|
|
|
|
| Andhra Pradesh |
|
News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts: Classifieds | Jobs | Obituary |
Andhra Pradesh
Special Correspondent
HYDERABAD: Acambis plc and Bharat Biotech have commenced paediatric clinical trial of "ChimeriVax-JE, its investigational single-dose vaccine against Japanese encephalitis (JE), in India. According to a press release here on Tuesday, Acambis announced that ChimerVax-JE, once approved, would be marketed and distributed in India and neighbouring countries by Bharat Biotech. Countries such as India, China, Thailand, and Japan were identified as JE-endemic regions in the world.
Printer friendly
page
News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
|
![]()
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Home |
Copyright © 2007, The
Hindu. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu
|